The World Health Organization (WHO) recommends conducting G6PD screening for newborns if the male prevalence of deficiency is 3%–5% (WHO Working Group, 1989 19). The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.